Davide Gianni is a highly experienced scientific professional with significant contributions in gene therapy and pharmacology, currently serving as a Scientific Director at Biogen since January 2013. In this role, Davide has developed AAV-based clinical candidates targeting neuromuscular and neurodegenerative disorders and led IND-enabling studies. Previously, positions at Biogen included Associate Scientific Director and Principal Scientist, with a focus on identifying molecular targets for neurodegenerative diseases and developing associated assays. Davide's academic foundation includes a PhD in Biochemistry from Imperial College London and a BSc/MS in Biotechnology from Università degli Studi di Milano, complemented by research fellowships at notable institutions such as Massachusetts General Hospital and UMass Medical School.
This person is not in the org chart
This person is not in any teams
This person is not in any offices